SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 3 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | – | 400 | 0.0% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 400 | 0.0% | 0.00% | – |
Q4 2021 | $1,000 | -66.7% | 400 | -38.0% | 0.00% | – |
Q3 2021 | $3,000 | -57.1% | 645 | -46.5% | 0.00% | – |
Q2 2021 | $7,000 | +40.0% | 1,206 | +65.7% | 0.00% | – |
Q1 2021 | $5,000 | -37.5% | 728 | 0.0% | 0.00% | – |
Q4 2020 | $8,000 | +100.0% | 728 | +82.0% | 0.00% | – |
Q3 2020 | $4,000 | -66.7% | 400 | -60.0% | 0.00% | – |
Q3 2018 | $12,000 | +20.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2018 | $10,000 | -23.1% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $10,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 200,000 | $1,768,000 | 8.83% |
Samsara BioCapital, LLC | 1,407,949 | $11,608,000 | 3.24% |
Flagship Pioneering Inc. | 2,938,494 | $25,976,000 | 0.72% |
ARK Investment Management | 11,212,506 | $99,119,000 | 0.59% |
Portolan Capital Management | 450,861 | $3,986,000 | 0.45% |
Capital Impact Advisors, LLC | 168,600 | $1,490,000 | 0.44% |
Nikko Asset Management Americas, Inc. | 4,182,346 | $36,261,000 | 0.32% |
Sio Capital Management, LLC | 166,780 | $1,474,000 | 0.29% |
Virtus ETF Advisers LLC | 34,835 | $308,000 | 0.16% |
Artal Group S.A. | 465,500 | $4,115,000 | 0.10% |